Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.

Authors

Véronique Minard-Colin
Anne Aupérin
Marta Pillon
G A Amos Burke
Donald A Barkauskas
Keith Wheatley
Rafael F Delgado
Sarah Alexander
Anne Uyttebroeck
Catherine M. Bollard, George Washington University
József Zsiros
Monika Csoka
Bernarda Kazanowska
Alan K Chiang
Rodney R Miles
Andrew Wotherspoon
Peter C Adamson
Gilles Vassal
Catherine Patte
Thomas G Gross

Document Type

Journal Article

Publication Date

6-4-2020

Journal

The New England Journal of Medicine

Volume

382

Issue

23

Inclusive Pages

2207-2219

DOI

10.1056/NEJMoa1915315

APA Citation

Minard-Colin, V., Aupérin, A., Pillon, M., Burke, G., Barkauskas, D., Wheatley, K., Delgado, R., Alexander, S., Uyttebroeck, A., Bollard, C. M., Zsiros, J., Csoka, M., Kazanowska, B., Chiang, A., Miles, R., Wotherspoon, A., Adamson, P., Vassal, G., Patte, C., & Gross, T. (2020). Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.. The New England Journal of Medicine, 382 (23). http://dx.doi.org/10.1056/NEJMoa1915315

Peer Reviewed

1